NGO information exchange

Aug 20th
Home arrow World Crises arrow Syria 2011 arrow Who's the next Big Pharma takeout target? Biogen, uniQure, AZ top the list: report
Who's the next Big Pharma takeout target? Biogen, uniQure, AZ top the list: report
User Rating: / 0
Wednesday, 26 June 2019
Investors were none too pleased with AbbVie’s planned $63 billion buyout of Allergan, which they made clear by shaving $18 billion off the acquirer’s market cap by the end of the day Tuesday. As the analysts at RBC Capital Markets in New York watched it all play out, they wondered, will there be....

Posted originally: 2019-06-26 18:29:00

Read Full Article
< Prev   Next >


How often do you receive first hand information about the UN from your radio & TV stations?

Crisis watch

  • Dura aterragem na Venezuela
    A Venezuela está à beira do precipício. A ação concertada ainda pode evitar a sua queda. Mas quanto mais se atrase, mais venezuelanos morrerão por falta de medicamentos, pela má nutrição ou pela violência.
  • South China Sea Ruling Sweeps Away Diplomatic Ambiguities
    Tuesday?s ruling by the International Tribunal on the Law of the Sea has bought a little clarity to the problems in the South China Sea, but it has not made solving the underlying problems significantly...
  • China Hardens Position on South China Sea
    China has taken a leap towards clarifying its claims in the South China Sea, but in a direction that could intensify frictions.
  • Erdo?an?s Pyrrhic victory
    Paradoxes have always abounded in the relationship between the Turkish military and the country?s politicians. Turkey?s armed forces ? or factions within them ? have justified their repeated interventions in politics with claims that they...
  • Venezuela?s hard landing
    Venezuela is on the edge of the precipice. Concerted action may yet pull it back. But the longer it is delayed, the more Venezuelans will die from lack of medicines, malnutrition or violence.